7 results
·
19ms
·
Sources: EU EUDAMED, US FDA
Electric wheelchair (JJW-7002, JJW-7003)
FDA 510(k)
FDA Class 2
·Physical Medicine
General Radiography CXDI-CS01
FDA 510(k)
FDA Class 2
·Radiology
SafeOp 2: Neural Informatix System
FDA 510(k)
FDA Class 2
·Neurology
VITALITY 2 VR
FDA Adverse Event
Injury
·CARDIAC PACEMAKERS, INC·Product code LWS·November 11, 2008
AFFINITY 4
FDA Adverse Event
Malfunction
·HILL-ROM, INC.·Product code HDD·August 11, 2011
2520274-2013-04810
FDA Adverse Event
Injury
·SYNTHES USA·Product code HWC·July 30, 2013
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014